Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	23.50	18.19	14.73
Graham Fair Price	-13.33	2712.88	3129.95
PEG	-53.04	-0.38	0.80
Price/Book	2.72	0.58	0.57
Price/Cash Flow	42.72	21.88	15.33
Prices/Earnings	52.03	10.85	7.13
Price/Sales	23.12	1.33	1.08
Price/FCF	42.72	21.88	15.33
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.34	0.12	0.12
Operating Margin	-17.67	0.04	0.05
ROA	-30.10	< 0.005	< 0.005
ROE	0.02	0.01	-32.44
ROIC	0.02	< 0.005	-48.05
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.04	-0.05	26.56
Dividends QOQ	-1.00	464.34	46457.70
EBIT QOQ	0.03	-0.28	746.16
EPS QOQ	0.09	-0.29	223.74
FCF QOQ	-0.23	-0.24	-5.52
Revenue QOQ	0.08	-0.12	44.83
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	77.38	89.96	16.26
Days Sales Outstanding (DSO)	72.77	79.70	9.52
Inventory Turnover	1.16	1.00	-13.99
Debt/Capitalization	0.32	0.30	-5.47
Quick Ratio	0.78	0.78	-1.17
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4674.41	4929.00	5.45
Cash	874.03	861.53	-1.43
Capex	-168.78	-104.76	37.93
Free Cash Flow	173.38	131.58	-24.11
Revenue	2455.33	2160.10	-12.02
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.33	1.34	1.05
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.02	5.63	12.11
Naive Interpretation	Member

06 - Financial Health · Weak

Rating